Nihon Kohden (OTCMKTS:NHNKY) Sees Large Volume Increase – Still a Buy?

Nihon Kohden Corporation (OTCMKTS:NHNKY) saw an uptick in trading volume on Monday . Approximately 22,371 shares were traded during mid-day trading, a decline of 17% from the previous session’s volume of 26,951 shares.The stock last traded at $9.48 and had previously closed at $9.2850.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded Nihon Kohden to a “hold” rating in a report on Monday, April 27th. One research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Buy”.

Nihon Kohden Stock Up 2.2%

The stock has a market cap of $1.59 billion, a PE ratio of 16.09 and a beta of 0.39. The stock’s fifty day moving average price is $8.97 and its 200 day moving average price is $9.96.

Nihon Kohden (OTCMKTS:NHNKY) last announced its quarterly earnings data on Thursday, May 14th. The company reported $0.34 earnings per share for the quarter, topping analysts’ consensus estimates of $0.24 by $0.10. Nihon Kohden had a net margin of 6.08% and a return on equity of 9.46%. The company had revenue of $453.10 million during the quarter, compared to analyst estimates of $414.40 million. On average, equities research analysts expect that Nihon Kohden Corporation will post 0.6 earnings per share for the current fiscal year.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.